Printer Friendly

U.S. BIOSCIENCE NAMES MARTHA MANNING VICE PRESIDENT, GENERAL COUNSEL

 WEST CONSHOHOCKEN, Pa., May 17 /PRNewswire/ -- U.S. Bioscience, Inc. (AMEX: UBS), announced today that Martha E. Manning, Esq., has been named vice president, general counsel and corporate secretary of this pharmaceutical firm.
 Manning came to U.S. Bioscience from The Wistar Institute, a prominent biotechnology research organization based in Philadelphia, where she was a general counsel. A graduate of the University of Pennsylvania School of Law, she had previously been an associate with the law firm of Morgan, Lewis & Bockius specializing in corporate, commercial and securities law.
 Philip S. Schein, M.D., chairman and chief executive officer, noted that while Manning has a broad range of experience in various aspects of the legal profession, her exceptional expertise in business development will complement the company's expanding activities in this area.
 Based in West Conshohocken, U.S. Bioscience is a pharmaceutical company specializing in the development and commercialization of products to increase the survival and quality of life for patients with cancer and allied diseases. The company's portfolio includes a broad spectrum of compounds, including two products for which new drug applications have been filed and two others in the late stages of development. One compound, altretamine, is marketed under the name Hexalen in the United States for the treatment of ovarian cancer.
 -0- 5/17/93
 /NOTE: Hexalen is a registered trademark./
 /CONTACT: Robert I. Kriebel, senior vice president, finance and administration, U.S. Bioscience, 215-832-4503/
 (UBS)


CO: U.S. Bioscience, Inc. ST: Pennsylvania IN: MTC SU: PER

KD-TW -- DC003 -- 9026 05/17/93 08:58 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 17, 1993
Words:257
Previous Article:WAXMAN INDUSTRIES REPORTS RESULTS FOR THIRD QUARTER OF FISCAL 1993
Next Article:KMART CORPORATION REPORTS 1993 FIRST-QUARTER SALES AND EARNINGS
Topics:


Related Articles
CORTECH APPOINTS KENNETH R. LYNN PRESIDENT AND CEO

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters